Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2007
08/01/2007EP1813623A1 Purinenucleoside derivative modified in 8-position and medicinal use thereof
08/01/2007EP1813611A1 1-substituted-3- beta-d-glucopyranosylated nitrogenous hetero- cyclic compounds and medicines containing the same
08/01/2007EP1813287A1 Type ii cubic liquid crystal composition
08/01/2007EP1813286A2 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound
08/01/2007EP1813284A1 Pharmaceutical composition
08/01/2007EP1813283A1 Remedy for neuropathic pain
08/01/2007EP1813278A1 Nucleoside analogs with carboxamidine modified monocyclic base
08/01/2007EP1812797A2 Compositions and methods for the treatment and prevention of hyperproliferative diseases
08/01/2007EP1812794A2 Autocrine growth factor receptors and methods
08/01/2007EP1812597A2 Mammalian genes involved in infection
08/01/2007EP1812574A2 Soluble bifunctional proteins
08/01/2007EP1812550A2 Biocides
08/01/2007EP1812474A2 Multi-domain amphipathic helical peptides and methods of their use
08/01/2007EP1812468A2 Platelet factor 4 variant 1 (pf4var1) related inhibitors of angiogenesis
08/01/2007EP1812467A1 PEPTIDE ABLE TO BREAK THE m-p53/p63, m-p53/ p73 AND m-p53/RESPECTIVE ISOFORM PROTEINS COMPLEX FORMED IN THE TUMOR CELLS AND USES THEREOF IN THE PHARMACOLOGICAL FIELD
08/01/2007EP1812466A2 Compositions and methods for the control of mammary cell number
08/01/2007EP1812465A1 Novel composition and methods for the treatment of immune related diseases
08/01/2007EP1812463A2 Group 2 mite polypeptide variants
08/01/2007EP1812462A2 Vwfa and/or ant_ig domain containing proteins
08/01/2007EP1812460A1 Formulations, methods of production and uses of fgf-20
08/01/2007EP1812082A2 Toxins and radionuclides coupled to igf-1 receptor ligands for treatment of cancer
08/01/2007EP1812077A2 Modulators of epha2 and ephrina1 for the treatment of fibrosis-related disease
08/01/2007EP1812076A2 Platelet-derived growth factor compositions and methods of use thereof
08/01/2007EP1812055A1 Chlamydia antigens and uses thereof
08/01/2007EP1812049A2 Kallikrein inhibitors and uses thereof
08/01/2007EP1812048A1 Gh secretagogues and uses thereof
08/01/2007EP1812047A1 Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds
08/01/2007EP1812046A2 Melanocortin receptor binding mimetibodies, compositions, methods and uses
08/01/2007EP1812045A2 Uses of secretagogues for treatment of organ transplant patients
08/01/2007EP1812044A2 Uses of growth hormone secretagogues in the treatment of individuals suffering from renal and/or liver failure
08/01/2007EP1812043A1 Pharmaceutical preparation for the treatment of friedreich' s ataxia
08/01/2007EP1812042A1 Rehydration compositions comprising epidermal growth factor
08/01/2007EP1812039A1 Prodrugs of ribavirin with improved hepatic delivery
08/01/2007EP1812038A1 Fibronectin iii domain as leptin receptor antagonists
08/01/2007EP1812037A2 Novel cyclosporin alkynes and their utility as pharmaceutical agents
08/01/2007EP1812036A2 Histone deacetylase inhibitors and methods of use
08/01/2007EP1812035A2 Peptide anti - tumor agent
08/01/2007EP1812034A1 Compositions and methods for inducing melanogenesis in a subject
08/01/2007EP1812033A2 Method and composition for enhancing anti-angiogenic therapy
08/01/2007EP1812032A2 Tissue factor composition and methods
08/01/2007EP1812031A2 Compositions and methods for modification of biomolecules
08/01/2007EP1812030A2 Anti-angiogenic peptides and methods of use thereof
08/01/2007EP1812020A1 Presbyopia treatment by lens alteration
08/01/2007EP1811966A2 Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
08/01/2007EP1811867A2 Food composition comprising a protein- and a lipid fraction for rapidly attenuating inflammatory responses
08/01/2007EP1811842A2 3,3'-diindolylmethane immune activating compositions
08/01/2007EP1811838A2 Tweak as a therapeutic target for treating central nervous system diseases associated with cerebral edema and and cell death
08/01/2007EP1715888B1 Treatment of abnormalities of the first metatarsophalangeal joint of the foot
08/01/2007EP1687402A4 Chimeric metabotropic glutamate receptors and uses thereof
08/01/2007EP1636261B1 Thrombopoietin proteins with improved properties
08/01/2007EP1572071A4 Systems and methods for treating patients with processed lipoaspirate cells
08/01/2007EP1556494B1 Bicistronic vector encoding a vegf and an fgf, use thereof
08/01/2007EP1539221A4 Transferrin fusion protein libraries
08/01/2007EP1516184B1 Cell-selective delivery system
08/01/2007EP1470226B1 Control of gene expression using a complex of an oligonucleotide and a regulatory peptide
08/01/2007EP1424074B1 Nutritional compositions for controlling blood glucose level
08/01/2007EP1381681B1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use
08/01/2007EP1377542B1 Hiv protease inhibitors based on amino acid derivatives
08/01/2007EP1344821B1 Novel aggrecanase
08/01/2007EP1323425B1 Composition for diminishing neutral fat in blood
08/01/2007EP1294401B1 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents
08/01/2007EP1214339B1 Polypeptides from moraxella (branhamella) catarrhalis
08/01/2007EP1185615B1 Recombinant influenza viruses for vaccines and gene therapy
08/01/2007EP1141293B1 Vascular endothelial growth factor-x
08/01/2007EP1082410B1 Human cd45+ and/or fibroblast + mesenchymal stem cells
08/01/2007EP1018879B1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
08/01/2007EP1007537B1 Receptor protein designated 2f1
08/01/2007EP0948344B1 Synthetic antibiotics
08/01/2007EP0929310B1 Diagnostic and therapeutic methods related to regulating energy mobilization with ob protein and ob antibodies
08/01/2007EP0884947B1 Dna vaccination for induction of suppressive t cell response
08/01/2007CN1329512C Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors
08/01/2007CN1329409C Modulation of the expression of genes dependent on STAT-1
08/01/2007CN1329397C Cross-linked glycopeptide-cephalosporin antibiotics
08/01/2007CN1329082C Polymer conjugates of interferon beta-1a and their uses
08/01/2007CN1329080C Cachexia remedy
08/01/2007CN1329078C Agents promoting proliferation and/or differentiation of hematopoietic stem cells and/or hematopoietic precursor cells
08/01/2007CN1329077C Protein preparation for enhancing sclerotin and its preparation method
08/01/2007CN101010430A RAGE fusion proteins and methods of use
08/01/2007CN101010341A Vaccine composition comprising a class ii cmh ligand coupledwith an antigen, method for the preparation and the use thereof
08/01/2007CN101010340A Glp-1 and exendin related invention
08/01/2007CN101010338A Muteins of fibroblast growth factor 21
08/01/2007CN101010337A Fas associated factor 1
08/01/2007CN101010335A Methods and compositions for the treatment of gastrointestinal disorders
08/01/2007CN101010101A Composition comprising protein material and non-oxidizable fatty acid entities
08/01/2007CN101010100A Treatment of cancer
08/01/2007CN101010097A Hai-1 and hai-2 in cancer therapy
08/01/2007CN101010096A Cyclic peptides for treatment of cachexia
08/01/2007CN101010095A Cyclic peptides for treatment of cachexia
08/01/2007CN101010094A Guanylhydrazone salts, compositions, processes of making and methods of using
08/01/2007CN101010083A Methods and reagents for the treatment of metabolic disorders
08/01/2007CN101010001A NGAL for reduction and amelioration of ischemic and nephrotoxic injuries
08/01/2007CN101008012A Novel human-derived neurotrophic factor BDNF expression structure and its expression
08/01/2007CN101007852A Natural antibacterial agent-recombinant chicken-beta defensins Gal-9-Gal-8 double-molecule protein preparation method
08/01/2007CN101007851A Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen
08/01/2007CN101007850A Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen
08/01/2007CN101007848A Long chain human insulin-like growth factor(LR3IGF-1) and its preparing process and application method
08/01/2007CN101007846A T8 synthetic product and application thereof
08/01/2007CN101007844A Synthetic peptides and methods for treating cancer invasion and metastasis
08/01/2007CN101007843A Peptide drug preparation method and application
08/01/2007CN101007842A T4 synthetic product and application thereof
1 ... 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 ... 3163